Cindy Berejikian
Operationeel Directeur bij MINERALYS THERAPEUTICS, INC.
Actieve functies van Cindy Berejikian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Operationeel Directeur | - | - |
Loopbaan van Cindy Berejikian
Eerdere bekende functies van Cindy Berejikian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AMGEN INC. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - | |
| OTONOMY | Corporate Officer/Principal | 04-02-2011 | - |
Opleiding van Cindy Berejikian
| University of California, Los Angeles | Masters Business Admin |
| University of California, Santa Barbara | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Cindy Berejikian
- Ervaring
